Dassault Systèmes announces the launch of the first model of the world based on virtual 3D simulation of the whole human heart. Developed with a multidisciplinary team of experts to help fight cardiovascular disease, “Living Heart” project will mark a new frontier in the diagnosis, treatment and prevention of heart disease through personalized 3D virtual models.
According to recent research from the World Health Organization, 17.3 million people died from cardiovascular diseases worldwide in 2008, representing 30% of all deaths. A report from the American Heart Association Forecasting the Future of Cardiovascular Disease in the United States consider actual direct medical costs of cardiovascular disease will reach 81,810 million dollars over the next 30 years.
In the center of the project is a 3D heart made with applications of virtual simulation platform Dassault Systèmes 3DEXPERIENCE platform. The simulation experts of the company have used the latest advances introduced in the SIMULIA applications to develop a complete 3D model of this organ, capturing the electrical and mechanical heart as realistic as possible and live performance.
Currently, the lack of realistic 3D human model limits the ability of researchers to predict the behavior of the devices in people. The Living Heart project has attracted a community of regulators multidisciplinary medical researchers, health professionals, device manufacturers and industry regulators, who have access to 3D computer modeling to accelerate the transformation of research into products and services for the market.
Using echocardiography, MRI images and CT scanner with cardiac screening data, the personalized heart 3D simulations will soon allow medical professionals to better understand the behavior of a patient’s heart without the need for additional invasive diagnostic procedures.
This is useful for those with congenital heart defects, which necessarily require many cardiovascular treatments, but also for the large percentage of population suffering from heart failure, arrhythmias, and other structural abnormalities. This technology is a breakthrough that will accelerate the realization of our scientific advances on cardiac function in practical applications that promote better health and safety.
This realistic simulation of a human heart is a valuable educational and explanatory tool that promotes innovation in research, accelerates the cycles of regulatory approvals, reduces development costs of new custom devices and eventually will provide early diagnosis and improved treatment results.
SOLACI.ORG
